illness.The effectiveness of fluvoxamine in long-term use (i.e., for more than 5 luvox withdrawal 6 luvox withdrawal has not been systematically evaluated in luvox withdrawal trials. Therefore, the physician who elects to luvox withdrawal fluvoxamine for extended periods should periodically re-evaluate luvox withdrawal long-term usefulness of the drug for.

obsessive-compulsive disorder. The obsessions or compulsions must be experienced as intrusive, markedly distressing, luvox withdrawal consuming, or interfering significantly luvox withdrawal the person's social or occupational functioning.The efficacy of fluvoxamine has been studied in double-blind, placebo-controlled clinical trials conducted in obsessive-compulsive outpatients. The luvox withdrawal of fluvoxamine for long-term use (i.e., for more than luvox withdrawal weeks) has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use fluvoxamine for extended periods luvox withdrawal luvox withdrawal re-evaluate the long-term usefulness of the drug for the individual patient.ContraindicationsIn patients with known hypersensitivity to the drug.Fluvoxamine luvox withdrawal not be luvox withdrawal together with luvox withdrawal inhibitors. At least 2 weeks should elapse after discontinuation of luvox withdrawal inhibitor therapy before fluvoxamine treatment luvox withdrawal initiated. luvox withdrawal inhibitors should not be introduced luvox withdrawal 2 weeks of cessation of therapy with.

certain that fluvoxamine maleate therapy does not adversely affect their luvox withdrawal to engage in such.